Atossa Genetics Price to Sales Ratio 2012-2025 | ATOS
Historical PS ratio values for Atossa Genetics (ATOS) over the last 10 years. The current P/S ratio for Atossa Genetics as of December 12, 2025 is .
| Atossa Genetics P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-12-12 | 0.83 | 0.00 | |
| 2025-09-30 | 0.87 | 0 | 0.00 |
| 2025-06-30 | 0.83 | 0 | 0.00 |
| 2025-03-31 | 0.67 | 0 | 0.00 |
| 2024-12-31 | 0.94 | 0 | 0.00 |
| 2024-09-30 | 1.52 | 0 | 0.00 |
| 2024-06-30 | 1.19 | 0 | 0.00 |
| 2024-03-31 | 1.80 | 0 | 0.00 |
| 2023-12-31 | 0.88 | 0 | 0.00 |
| 2023-09-30 | 0.74 | 0 | 0.00 |
| 2023-06-30 | 1.26 | 0 | 0.00 |
| 2023-03-31 | 0.72 | 0 | 0.00 |
| 2022-12-31 | 0.53 | 0 | 0.00 |
| 2022-09-30 | 0.83 | 0 | 0.00 |
| 2022-06-30 | 1.09 | 0 | 0.00 |
| 2022-03-31 | 1.25 | 0 | 0.00 |
| 2021-12-31 | 1.60 | 0 | 0.00 |
| 2021-09-30 | 3.26 | 0 | 0.00 |
| 2021-06-30 | 6.32 | 0 | 0.00 |
| 2021-03-31 | 2.11 | 0 | 0.00 |
| 2020-12-31 | 0.95 | 0 | 0.00 |
| 2020-09-30 | 2.42 | 0 | 0.00 |
| 2020-06-30 | 3.80 | 0 | 0.00 |
| 2020-03-31 | 1.33 | 0 | 0.00 |
| 2019-12-31 | 1.57 | 0 | 0.00 |
| 2019-09-30 | 1.96 | 0 | 0.00 |
| 2019-06-30 | 2.55 | 0 | 0.00 |
| 2019-03-31 | 3.52 | 0 | 0.00 |
| 2018-12-31 | 1.02 | 0 | 0.00 |
| 2018-09-30 | 1.75 | 0 | 0.00 |
| 2018-06-30 | 2.20 | 0 | 0.00 |
| 2018-03-31 | 5.35 | 0 | 0.00 |
| 2017-12-31 | 3.16 | 0 | 0.00 |
| 2017-09-30 | 6.36 | 0 | 0.00 |
| 2017-06-30 | 6.00 | 0 | 0.00 |
| 2017-03-31 | 9.12 | 0 | 0.00 |
| 2016-12-31 | 16.92 | 0 | 0.00 |
| 2016-09-30 | 25.20 | 0 | 0.00 |
| 2016-06-30 | 50.40 | 0 | 0.00 |
| 2016-03-31 | 61.92 | 0 | 0.00 |
| 2015-12-31 | 57.60 | 0 | 0.00 |
| 2015-09-30 | 138.60 | $0.02 | 6858.13 |
| 2015-06-30 | 203.40 | $0.05 | 4504.53 |
| 2015-03-31 | 324.00 | $0.12 | 2743.21 |
| 2014-12-31 | 257.40 | $0.30 | 870.46 |
| 2014-09-30 | 243.00 | $0.82 | 294.78 |
| 2014-06-30 | 302.40 | $1.67 | 181.09 |
| 2014-03-31 | 304.20 | $5.56 | 54.72 |
| 2013-12-31 | 417.60 | $7.83 | 53.33 |
| 2013-09-30 | 1011.60 | $8.71 | 116.21 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.107B | $0.000B |
| Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $215.010B | 25.55 |
| Intuitive Surgical (ISRG) | United States | $194.409B | 76.06 |
| IDEXX Laboratories (IDXX) | United States | $56.231B | 55.84 |
| Edwards Lifesciences (EW) | United States | $48.211B | 32.33 |
| Alcon (ALC) | Switzerland | $38.868B | 26.27 |
| IQVIA Holdings (IQV) | United States | $37.851B | 21.11 |
| Mettler-Toledo (MTD) | United States | $28.469B | 33.31 |
| DexCom (DXCM) | United States | $26.115B | 36.00 |
| STERIS (STE) | Ireland | $24.712B | 25.51 |
| Waters (WAT) | United States | $22.941B | 30.34 |
| Hologic (HOLX) | United States | $16.718B | 17.56 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.969B | 0.00 |
| Penumbra (PEN) | United States | $12.219B | 85.96 |
| Globus Medical (GMED) | United States | $11.604B | 24.35 |
| Masimo (MASI) | United States | $7.431B | 23.81 |
| Glaukos (GKOS) | United States | $6.254B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $5.835B | 18.54 |
| Teleflex (TFX) | United States | $5.607B | 8.94 |
| TransMedics (TMDX) | United States | $4.333B | 51.33 |
| LivaNova (LIVN) | United Kingdom | $3.427B | 18.51 |
| Veracyte (VCYT) | United States | $3.386B | 38.59 |
| Alphatec Holdings (ATEC) | United States | $2.965B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.548B | 11.96 |
| Elekta AB (EKTAY) | Sweden | $2.183B | 20.42 |
| Artivion (AORT) | United States | $2.138B | 98.09 |
| PROCEPT BioRobotics (PRCT) | United States | $2.011B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.826B | 15.94 |
| UFP Technologies (UFPT) | United States | $1.692B | 22.35 |
| Tandem Diabetes Care (TNDM) | United States | $1.450B | 0.00 |
| AxoGen (AXGN) | United States | $1.402B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.310B | 0.00 |
| IRadimed (IRMD) | United States | $1.224B | 58.32 |
| OPKO Health (OPK) | United States | $1.059B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.045B | 5.66 |
| Pulse Biosciences (PLSE) | United States | $0.965B | 0.00 |
| SiBone (SIBN) | United States | $0.807B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.640B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.621B | 36.13 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.613B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.545B | 10.88 |
| AngioDynamics (ANGO) | United States | $0.541B | 0.00 |
| NeuroPace (NPCE) | United States | $0.539B | 0.00 |
| RxSight (RXST) | United States | $0.519B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.441B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.429B | 11.86 |
| Alpha Tau Medical (DRTS) | Israel | $0.428B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.428B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.366B | 61.00 |
| ClearPoint Neuro (CLPT) | United States | $0.361B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.275B | 2.05 |
| Spectral Diagnostics (EDTXF) | Canada | $0.269B | 0.00 |
| CVRx (CVRX) | United States | $0.221B | 0.00 |
| 908 Devices (MASS) | United States | $0.216B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.211B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.205B | 0.00 |
| Inogen (INGN) | United States | $0.192B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.178B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.162B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.161B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.160B | 0.00 |
| Solana (HSDT) | United States | $0.139B | 0.00 |
| LENSAR (LNSR) | United States | $0.137B | 0.00 |
| Accuray (ARAY) | United States | $0.120B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.109B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.108B | 0.00 |
| Neuronetics (STIM) | United States | $0.104B | 0.00 |
| Hyperfine (HYPR) | United States | $0.097B | 0.00 |
| InspireMD (NSPR) | United States | $0.083B | 0.00 |
| DarioHealth (DRIO) | United States | $0.080B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.073B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.063B | 0.00 |
| Positron (POSC) | United States | $0.050B | 0.00 |
| Spectral AI (MDAI) | United States | $0.049B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.037B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.023B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| Tenon Medical (TNON) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.35 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |